The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - The Fulham Shore plc

21 Apr 2023 17:07

RNS Number : 1175X
Fulham Shore PLC (The)
21 April 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Fulham Shore plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

The Fulham Shore plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

21 April 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of £0.01 each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0.00

Nil

0.00

(2) Cash-settled derivatives:

 

Nil

0.00

Nil

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0.00

Nil

0.00

 

TOTAL:

Nil

0.00

Nil

0.00

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Holdings of ordinary shares by the directors of The Fulham Shore plc (the "Company") and their close relatives:

 

Name

Number of

Ordinary Shares beneficially interested in

Number of

Ordinary Shares

held by

close relatives

Total Number

Of Ordinary

Shares

% of total issued share capital (total)

David Page

83,515,120

7,827,695

91,342,815

14.38%

Nabil Mankarious

116,779,434

2,695,188

119,474,622

18.81%

Nicholas Wong

12,388,449

Nil

12,388,449

1.95%

Nicholas Donaldson

14,998,573

Nil

14,998,573

2.36%

Martin Chapman

1,086,818

181,800

1,268,618

0.20%

Desmond Gunewardena

774,545

Nil

774,545

0.12%

 

b) The directors of the Company have the following rights to subscribe for the following relevant The Fulham Shore plc securities:

 

Name

Plan

Date of Grant

Option Exercise price (p)

Expiry Date

Number outstanding

David Page

Unapproved

21 April 2015

11p

21 April 2025

4,732,795

Nabil Mankarious

Unapproved

21 April 2015

11p

21 April 2025

4,732,795

Nicholas Wong

Unapproved

21 April 2015

11p

21 April 2025

4,732,795

Nicholas Donaldson

Unapproved

21 April 2015

11p

21 April 2025

4,732,795

Martin Chapman

Unapproved

21 April 2015

11p

21 April 2025

2,366,397

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

21 April 2023

Contact name:

Nick Wong, Finance Director

Telephone number:

Via Hudson Sandler

Telephone: 020 7796 4133

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DCCUARNROVUSUAR
Date   Source Headline
10th Jan 20087:01 amRNSProposed Board Changes
20th Dec 20075:35 pmRNSResult of AGM
26th Nov 20077:01 amRNSFinal Results
15th Nov 20077:01 amRNSNotice of Results/Trdg Update
6th Nov 20077:01 amRNSOpening of new US office
11th Oct 20077:01 amRNSContract Win
7th Sep 20077:01 amRNSRe Alliance
3rd Sep 20074:13 pmRNSDirector/PDMR Shareholding
20th Aug 20074:09 pmRNSDirector/PDMR Shareholding
17th Aug 20074:37 pmRNSAIM Rule 26
15th Aug 20077:01 amRNSTrading Update
17th May 20077:01 amRNSInterim Results
18th Apr 20074:46 pmRNSDirector/PDMR Shareholding
12th Apr 20071:40 pmRNSEGM Statement
19th Mar 200711:28 amRNSPlacing and Acquisition
21st Feb 20077:00 amRNSCompletion of Earn Out
21st Dec 20069:29 amRNSTotal Voting Rights
18th Dec 200612:52 pmRNSResult of AGM
15th Nov 20062:06 pmRNSDirector/PDMR Shareholding
9th Nov 20067:01 amRNSFinal Results
2nd Aug 20067:00 amRNSDirector/PDMR Shareholding
12th May 20067:01 amRNSEdinburgh Office Opens
9th May 20067:01 amRNSInterim Results
12th Apr 200610:30 amRNSContract with Celtic Pharma
5th Apr 20067:01 amRNSNanoCarrier Partnership
7th Mar 20067:01 amRNSBoard Appointment
9th Feb 20067:01 amRNSAcquisition of Quadramed Ltd
19th Dec 200512:09 pmRNSAGM Statement
14th Nov 200512:18 pmRNSDirector/PDMR Shareholding
9th Nov 20057:00 amRNSPreliminary Results
14th Sep 20057:02 amRNSTrading Update
18th May 20057:01 amRNSSyngenta Biopharma Agreement
18th May 20057:00 amRNSInterim Results
5th May 200512:20 pmRNSNotice of Interim Results
1st Mar 20057:03 amRNSPresent at Networking Evening
25th Jan 20057:00 amRNSPresentation with Addex
6th Jan 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.